Inactive Instrument

News Abaco Capital PLC

Equities

GB00B3LXPB43

Summary

Unlock all the news: Be the first to know and act before the market!

Oxford Pharmascience : Completion of Demerger, Board Changes & Change of Company Name to Abaco Capital plc	17-12-21	PU
Oxford Pharmascience : Confirmation of Capital Reductions	17-12-19	PU
Oxford Pharmascience : Subdivision of Capital	17-12-04	PU
Oxford Pharmascience : FDA Pre-IND Advice on OXPzero™ Ibuprofen OTC Opportunity	17-11-29	PU
Oxford Pharmascience : Result of General Meeting	17-11-27	PU
Oxford Pharmascience : MPA Advice on OXPzero™ Ibuprofen OTC Opportunity	17-11-20	PU
Oxford Pharmascience : Announcement of demerger	17-11-10	PU
Oxford Pharmascience : MHRA Advice on OXPzero™ Ibuprofen OTC Opportunity	17-10-02	PU
Oxford Pharmascience : Interim results for the six months to 30 June 2017	17-09-25	PU
Oxford Pharmascience : Result of AGM	17-06-19	PU
Oxford Pharmascience : Further Update Regarding OXPzero™ Ibuprofen Programmes	17-06-08	PU
Oxford Pharmascience : Update regarding OXPzero™ Ibuprofen Programmes	17-05-09	PU
Oxford Pharmascience : FDA Pre-IND Feedback on OXPzero™ Ibuprofen Rx programme	17-03-31	PU
Oxford Pharmascience : Final Results for the year ended 31 December 2016	17-03-10	PU
Oxford Pharmascience : OXPzero™ Ibuprofen - Positive Exploratory PK Study Data	17-03-06	PU
Oxford Pharmascience : Shares Magazine Investor Evening Presentation	16-05-20	PU
Oxford Pharmascience : OXP to exhibit at the Master Investor Show 2016	16-04-22	PU
Oxford Pharmascience : Positive Regulatory Advice from MHRA	16-04-19	PU
Oxford Pharmascience : Grant of Share Options	16-03-11	PU
Oxford Pharmascience : Change of Registered Office	16-01-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Abaco Capital PLC

Equities

GB00B3LXPB43

Summary

Filters